top of page

Covid-19 vaccine approval to massively accelerate mRNA innovation

  • Writer: Laurent DECORY
    Laurent DECORY
  • Dec 16, 2020
  • 1 min read

With COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in infectious-diseases but also personalized cancer medicine, at a higher speed and lower cost than CAR-T or mono-clonal antibodies




Comentarios


bottom of page